Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Datapoints: trends in combined pharmacotherapy with stimulants for children.

Bhatara VS, Feil M, Hoagwood K, Vitiello B, Zima B.

Psychiatr Serv. 2002 Mar;53(3):244. No abstract available.

PMID:
11875215
2.

Pharmacotherapy of attention-deficit hyperactivity disorder.

Simeon JG, Wiggins DM.

Can J Psychiatry. 1993 Aug;38(6):443-8. Review.

PMID:
8104678
3.

Non-stimulant trials of adult ADHD.

Adler LA.

CNS Spectr. 2007 Apr;12(4 Suppl 6):11-3. Review. No abstract available.

PMID:
17717871
4.

Psychotropic drug therapy in children and adolescents.

Wiener JM.

Psychosomatics. 1982 May;23(5):488-91, 494-5. Review. No abstract available.

PMID:
6125987
5.

Managing ADHD.

Baren M.

Contemp Pediatr. 1994 Dec;11(12):29-30, 33-4, 37-8 passim. Review.

PMID:
10150283
6.

Innovations and recent trends in the treatment of ADHD.

Madaan V, Kinnan S, Daughton J, Kratochvil CJ.

Expert Rev Neurother. 2006 Sep;6(9):1375-85. Review.

PMID:
17009924
7.

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S; American Academy of Child and Adolescent Psychiatry.

J Am Acad Child Adolesc Psychiatry. 2002 Feb;41(2 Suppl):26S-49S. Review.

PMID:
11833633
9.

[Attention deficit hyperactivity disorders in children and adolescents: diagnostic and therapeutic guidelines].

Lehmkuhl G.

MMW Fortschr Med. 2007 May 21;149 Suppl 2:10-3; quiz 14. Review. German.

PMID:
17724960
10.

Management of psychopharmacologic agents in children and adolescents.

Carlson GA, Ranade L, Qadir A.

Psychiatr Q. 1992 Winter;63(4):391-411. Review. No abstract available.

PMID:
1361998
11.

[Alternative agents used in ADHD].

Hässler F, Dück A, Reis O, Buchmann J.

Z Kinder Jugendpsychiatr Psychother. 2009 Jan;37(1):13-24, quiz 24-5. doi: 10.1024/1422-4917.37.1.13. Review. German.

PMID:
19105161
12.

Pharmacotherapy of attention deficit hyperactivity disorder.

Spencer T, Biederman J, Wilens T.

Child Adolesc Psychiatr Clin N Am. 2000 Jan;9(1):77-97. Review.

PMID:
10674191
13.

Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy.

Noorbala AA, Akhondzadeh S.

Arch Iran Med. 2006 Oct;9(4):374-80. Review.

PMID:
17061613
14.

Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder.

Kollins SH, March JS.

Biol Psychiatry. 2007 Nov 1;62(9):951-3. Review. No abstract available.

PMID:
17950067
15.

An update on assessment and treatment of complex attention-deficit hyperactivity disorder.

Hunt RD, Paguin A, Payton K.

Pediatr Ann. 2001 Mar;30(3):162-72. Review. No abstract available.

PMID:
11257946
16.

Optimizing therapy of seizures in children and adolescents with ADHD.

Aldenkamp AP, Arzimanoglou A, Reijs R, Van Mil S.

Neurology. 2006 Dec 26;67(12 Suppl 4):S49-51. Review.

PMID:
17190923
17.

Attention deficit hyperactivity disorder in children.

Ramchandani P, Joughin C, Zwi M.

Clin Evid. 2002 Jun;(7):262-71. Review. No abstract available. Update in: Clin Evid. 2002 Dec;(8):280-90.

PMID:
12230649
18.

The stimulants.

Wilens TE, Biederman J.

Psychiatr Clin North Am. 1992 Mar;15(1):191-222. Review.

PMID:
1347939
19.

Long-term efficacy of ADHD pharmacotherapy in children.

Gilchrist RH, Arnold EL.

Pediatr Ann. 2008 Jan;37(1):46-51. Review. No abstract available.

PMID:
18240853
20.

[Is drug therapy of hyperactive children justified?].

Janols LO, von Knorring AL.

Lakartidningen. 1991 Sep 18;88(38):3057-8, 3061. Review. Swedish. No abstract available.

PMID:
1681156

Supplemental Content

Support Center